Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Дефекты нервной трубки: современные представления об этиологии, дородовой профилактике и возможностях ранней диагностики
Дефекты нервной трубки: современные представления об этиологии, дородовой профилактике и возможностях ранней диагностики
Чугунова Л.А., Пискулина А.А., Костюков К.В. Дефекты нервной трубки: современные представления об этиологии, дородовой профилактике и возможностях ранней диагностики. Consilium Medicum. 2023;25(8):491–496. DOI: 10.26442/20751753.2023.8.202350
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Представлен обзор литературных данных об этиологии, профилактике и возможностях ранней диагностики дефектов нервной трубки. Уделено внимание причинам и факторам риска развития данной патологии. Разбираются различные патогенетические механизмы формирования незаращения нервной трубки, в том числе роль фолиевой кислоты в профилактике его возникновения. Освещены основные этапы ультразвуковой оценки структур центральной нервной системы в I триместре беременности. Приведена методика получения основных ультразвуковых изображений, позволяющих идентифицировать открытый спинальный дизрафизм. Цель обзора – представление современных данных об этиологии, профилактике и возможностях ранней диагностики. По ключевым словам «дефект нервной трубки», «Spina bifida», «пренатальная диагностика», «фолиевая кислота», «менингомиелоцеле», «миелошизис» проведен анализ отечественных и зарубежных литературных баз данных: elibrary, Medline/PubMed, Embase, Crossref, РИНЦ. В соответствии с поставленной целью отобрано для анализа 25 источников литературы. Осведомленность практикующих специалистов о методах дородовой профилактики и возможностях ранней перинатальной ультразвуковой диагностики дефектов нервной трубки позволит снизить частоту данной патологии, уменьшить показатели детской заболеваемости и повысить эффективность оказания медицинской помощи.
Ключевые слова: дефект нервной трубки, spina bifida, пренатальная диагностика, фолиевая кислота, менингомиелоцеле, миелошизис
Keywords: neural tube defect, spina bifida, prenatal diagnosis, folic acid, meningomyelocele, myeloschisis
Ключевые слова: дефект нервной трубки, spina bifida, пренатальная диагностика, фолиевая кислота, менингомиелоцеле, миелошизис
________________________________________________
Keywords: neural tube defect, spina bifida, prenatal diagnosis, folic acid, meningomyelocele, myeloschisis
Полный текст
Список литературы
1. Демикова Н.С., Подольная М.А., Лапина А.С. Частота и временные тренды дефектов нервной трубки в регионах Российской Федерации. Российский вестник перинатологии и педиатрии. 2019;64(6):30-8 [Demikova NS, Podol'naia MA, Lapina AS. Chastota i vremennye trendy defektov nervnoi trubki v regionakh Rossiiskoi Federatsii. Rossiiskii vestnik perinatologii i pediatrii. 2019;64(6):30-8 (in Russian)].
2. Демикова Н.С., Лапина А.С., Подольная М.А., Кобринский Б.А. Динамика частоты врожденных пороков развития в РФ (по данным федеральной базы мониторинга ВПР за 2006–2012 гг.). Российский вестник перинатологии и педиатрии. 2015;60(2):72-7 [Demikova NS, Lapina AS, Podol'naia MA, Kobrinskii BA. Dinamika chastoty vrozhdennykh porokov razvitiia v RF (po dannym federal'noi bazy monitoringa VPR za 2006–2012 gg.). Rossiiskii vestnik perinatologii i pediatrii. 2015;60(2):72-7 (in Russian)].
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research CounISSUEcil Vitamin Study. Lancet. 1991;338(8760):131-7.
4. Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46:325-35.
5. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-24.
6. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol.
2007;79:187-210.
7. Gabriel L, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159.
DOI:10.1038/s41467-021-21372-4
8. Robinson A, Escuin S, Doudney K, et al. Mutations in the planar cell polarity genes CELSR1 and SCRIB are associated with the severe neural tube defect craniorachischisis. Hum Mutat. 2012;33(2)440-7. DOI:10.1002/humu.21662
9. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67:317-23.
10. Toepoel M, Steegers-Theunissen RP, Ouborg NJ, et al. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Birth Defects Res A Clin Mol Teratol. 2009;85(7):629-36. DOI:10.1002/bdra.20574
11. Egorova O, Myte R, Schneede J, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11(71):7. DOI:10.1186/s13229-020-0315-z
12. Paladini D, Malinger G, Birnbaum R, et al. ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 2: performance of targeted neurosonography. Ultrasound Obstet Gynecol. 2021;57(4):661-71. DOI:10.1002/uog.23616
13. Volpe N, Dall'Asta A, Di Pasquo E, et al. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204-14.
14. Kozlowski P, Burkhardt T, Gembruch U, et al. DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Med. 2019;40(2):176-93.
15. Tulipan N, Wellons JC 3rd, Thom EA; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015;16(6):613-20.
16. Houtrow AJ, Burrows PK, Thom EA. Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial. J Pediatr Rehabil Med. 2018;11(4):227-35.
17. Greene ND, Copp AJ. Models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet. 2005;135C(1):31-41. DOI:10.1002/ajmg.c.30051
18. Galea GL, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159. DOI:10.1038/s41467-021-21372-4
19. Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, I: the ventricular "point". J Ultrasound Med. 2008;27(1):33-8.
20. Callen AL, Stengel JW, Filly RA. Supratentorial abnormalities in the Chiari II malformation, II: tectal morphologic changes. J Ultrasound Med. 2009;28(1):29-35.
21. Wong SK, Barkovich JА, Сallen AL, Filly RA. Supratentorial Abnormalities in the Chiari II Malformation, III: The Interhemispheric Cyst. J Ultrasound Med. 2009;28(8):999-1006. DOI:10.7863/jum.2009.28.8.999
22. Filly MR, Filly RA, Barkovich AJ, Goldstein RB. Supratentorial Abnormalities in the Chiari II Malformation, IV: The Too-Far-Back Ventricle. J Ultrasound Med. 2010;29(2):243-48. DOI:10.7863/jum.2010.29.2.243
23. Finn M, Sutton D, Atkinson S, et al. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640-5. DOI:10.1002/uog.10088
24. Leibovitz Z, Shkolnik C, Krajden Haratz K, et al. Assessment of fetal midbrain and hindbrain in mid-sagittal cranial plane by three-dimensional multiplanar sonography. Part 1: comparison of new and established nomograms. Ultrasound Obstet Gynecol. 2014;44(5):575-80. DOI:10.1002/uog.13308.
25. Volcik KA, Shaw GM, Lammer EJ, et al. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol. 2003;67(3):154-7. DOI:10.1002/bdra.10008
2. Demikova NS, Lapina AS, Podol'naia MA, Kobrinskii BA. Dinamika chastoty vrozhdennykh porokov razvitiia v RF (po dannym federal'noi bazy monitoringa VPR za 2006–2012 gg.). Rossiiskii vestnik perinatologii i pediatrii. 2015;60(2):72-7 (in Russian).
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research CounISSUEcil Vitamin Study. Lancet. 1991;338(8760):131-7.
4. Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46:325-35.
5. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-24.
6. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol.
2007;79:187-210.
7. Gabriel L, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159.
DOI:10.1038/s41467-021-21372-4
8. Robinson A, Escuin S, Doudney K, et al. Mutations in the planar cell polarity genes CELSR1 and SCRIB are associated with the severe neural tube defect craniorachischisis. Hum Mutat. 2012;33(2)440-7. DOI:10.1002/humu.21662
9. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67:317-23.
10. Toepoel M, Steegers-Theunissen RP, Ouborg NJ, et al. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Birth Defects Res A Clin Mol Teratol. 2009;85(7):629-36. DOI:10.1002/bdra.20574
11. Egorova O, Myte R, Schneede J, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11(71):7. DOI:10.1186/s13229-020-0315-z
12. Paladini D, Malinger G, Birnbaum R, et al. ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 2: performance of targeted neurosonography. Ultrasound Obstet Gynecol. 2021;57(4):661-71. DOI:10.1002/uog.23616
13. Volpe N, Dall'Asta A, Di Pasquo E, et al. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204-14.
14. Kozlowski P, Burkhardt T, Gembruch U, et al. DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Med. 2019;40(2):176-93.
15. Tulipan N, Wellons JC 3rd, Thom EA; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015;16(6):613-20.
16. Houtrow AJ, Burrows PK, Thom EA. Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial. J Pediatr Rehabil Med. 2018;11(4):227-35.
17. Greene ND, Copp AJ. Models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet. 2005;135C(1):31-41. DOI:10.1002/ajmg.c.30051
18. Galea GL, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159. DOI:10.1038/s41467-021-21372-4
19. Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, I: the ventricular "point". J Ultrasound Med. 2008;27(1):33-8.
20. Callen AL, Stengel JW, Filly RA. Supratentorial abnormalities in the Chiari II malformation, II: tectal morphologic changes. J Ultrasound Med. 2009;28(1):29-35.
21. Wong SK, Barkovich JА, Сallen AL, Filly RA. Supratentorial Abnormalities in the Chiari II Malformation, III: The Interhemispheric Cyst. J Ultrasound Med. 2009;28(8):999-1006. DOI:10.7863/jum.2009.28.8.999
22. Filly MR, Filly RA, Barkovich AJ, Goldstein RB. Supratentorial Abnormalities in the Chiari II Malformation, IV: The Too-Far-Back Ventricle. J Ultrasound Med. 2010;29(2):243-48. DOI:10.7863/jum.2010.29.2.243
23. Finn M, Sutton D, Atkinson S, et al. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640-5. DOI:10.1002/uog.10088
24. Leibovitz Z, Shkolnik C, Krajden Haratz K, et al. Assessment of fetal midbrain and hindbrain in mid-sagittal cranial plane by three-dimensional multiplanar sonography. Part 1: comparison of new and established nomograms. Ultrasound Obstet Gynecol. 2014;44(5):575-80. DOI:10.1002/uog.13308.
25. Volcik KA, Shaw GM, Lammer EJ, et al. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol. 2003;67(3):154-7. DOI:10.1002/bdra.10008
2. Демикова Н.С., Лапина А.С., Подольная М.А., Кобринский Б.А. Динамика частоты врожденных пороков развития в РФ (по данным федеральной базы мониторинга ВПР за 2006–2012 гг.). Российский вестник перинатологии и педиатрии. 2015;60(2):72-7 [Demikova NS, Lapina AS, Podol'naia MA, Kobrinskii BA. Dinamika chastoty vrozhdennykh porokov razvitiia v RF (po dannym federal'noi bazy monitoringa VPR za 2006–2012 gg.). Rossiiskii vestnik perinatologii i pediatrii. 2015;60(2):72-7 (in Russian)].
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research CounISSUEcil Vitamin Study. Lancet. 1991;338(8760):131-7.
4. Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46:325-35.
5. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-24.
6. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol.
2007;79:187-210.
7. Gabriel L, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159.
DOI:10.1038/s41467-021-21372-4
8. Robinson A, Escuin S, Doudney K, et al. Mutations in the planar cell polarity genes CELSR1 and SCRIB are associated with the severe neural tube defect craniorachischisis. Hum Mutat. 2012;33(2)440-7. DOI:10.1002/humu.21662
9. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67:317-23.
10. Toepoel M, Steegers-Theunissen RP, Ouborg NJ, et al. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Birth Defects Res A Clin Mol Teratol. 2009;85(7):629-36. DOI:10.1002/bdra.20574
11. Egorova O, Myte R, Schneede J, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11(71):7. DOI:10.1186/s13229-020-0315-z
12. Paladini D, Malinger G, Birnbaum R, et al. ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 2: performance of targeted neurosonography. Ultrasound Obstet Gynecol. 2021;57(4):661-71. DOI:10.1002/uog.23616
13. Volpe N, Dall'Asta A, Di Pasquo E, et al. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204-14.
14. Kozlowski P, Burkhardt T, Gembruch U, et al. DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Med. 2019;40(2):176-93.
15. Tulipan N, Wellons JC 3rd, Thom EA; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015;16(6):613-20.
16. Houtrow AJ, Burrows PK, Thom EA. Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial. J Pediatr Rehabil Med. 2018;11(4):227-35.
17. Greene ND, Copp AJ. Models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet. 2005;135C(1):31-41. DOI:10.1002/ajmg.c.30051
18. Galea GL, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159. DOI:10.1038/s41467-021-21372-4
19. Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, I: the ventricular "point". J Ultrasound Med. 2008;27(1):33-8.
20. Callen AL, Stengel JW, Filly RA. Supratentorial abnormalities in the Chiari II malformation, II: tectal morphologic changes. J Ultrasound Med. 2009;28(1):29-35.
21. Wong SK, Barkovich JА, Сallen AL, Filly RA. Supratentorial Abnormalities in the Chiari II Malformation, III: The Interhemispheric Cyst. J Ultrasound Med. 2009;28(8):999-1006. DOI:10.7863/jum.2009.28.8.999
22. Filly MR, Filly RA, Barkovich AJ, Goldstein RB. Supratentorial Abnormalities in the Chiari II Malformation, IV: The Too-Far-Back Ventricle. J Ultrasound Med. 2010;29(2):243-48. DOI:10.7863/jum.2010.29.2.243
23. Finn M, Sutton D, Atkinson S, et al. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640-5. DOI:10.1002/uog.10088
24. Leibovitz Z, Shkolnik C, Krajden Haratz K, et al. Assessment of fetal midbrain and hindbrain in mid-sagittal cranial plane by three-dimensional multiplanar sonography. Part 1: comparison of new and established nomograms. Ultrasound Obstet Gynecol. 2014;44(5):575-80. DOI:10.1002/uog.13308.
25. Volcik KA, Shaw GM, Lammer EJ, et al. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol. 2003;67(3):154-7. DOI:10.1002/bdra.10008
________________________________________________
2. Demikova NS, Lapina AS, Podol'naia MA, Kobrinskii BA. Dinamika chastoty vrozhdennykh porokov razvitiia v RF (po dannym federal'noi bazy monitoringa VPR za 2006–2012 gg.). Rossiiskii vestnik perinatologii i pediatrii. 2015;60(2):72-7 (in Russian).
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research CounISSUEcil Vitamin Study. Lancet. 1991;338(8760):131-7.
4. Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46:325-35.
5. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-24.
6. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol.
2007;79:187-210.
7. Gabriel L, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159.
DOI:10.1038/s41467-021-21372-4
8. Robinson A, Escuin S, Doudney K, et al. Mutations in the planar cell polarity genes CELSR1 and SCRIB are associated with the severe neural tube defect craniorachischisis. Hum Mutat. 2012;33(2)440-7. DOI:10.1002/humu.21662
9. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67:317-23.
10. Toepoel M, Steegers-Theunissen RP, Ouborg NJ, et al. Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Birth Defects Res A Clin Mol Teratol. 2009;85(7):629-36. DOI:10.1002/bdra.20574
11. Egorova O, Myte R, Schneede J, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11(71):7. DOI:10.1186/s13229-020-0315-z
12. Paladini D, Malinger G, Birnbaum R, et al. ISUOG Practice Guidelines (updated): sonographic examination of the fetal central nervous system. Part 2: performance of targeted neurosonography. Ultrasound Obstet Gynecol. 2021;57(4):661-71. DOI:10.1002/uog.23616
13. Volpe N, Dall'Asta A, Di Pasquo E, et al. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204-14.
14. Kozlowski P, Burkhardt T, Gembruch U, et al. DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Med. 2019;40(2):176-93.
15. Tulipan N, Wellons JC 3rd, Thom EA; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015;16(6):613-20.
16. Houtrow AJ, Burrows PK, Thom EA. Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial. J Pediatr Rehabil Med. 2018;11(4):227-35.
17. Greene ND, Copp AJ. Models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C Semin Med Genet. 2005;135C(1):31-41. DOI:10.1002/ajmg.c.30051
18. Galea GL, Maniou E, Edwards TJ, et al. Cell non-autonomy amplifies disruption of neurulation by mosaic Vangl2 deletion in mice. Nat Commun. 2021;12(1):1159. DOI:10.1038/s41467-021-21372-4
19. Callen AL, Filly RA. Supratentorial abnormalities in the Chiari II malformation, I: the ventricular "point". J Ultrasound Med. 2008;27(1):33-8.
20. Callen AL, Stengel JW, Filly RA. Supratentorial abnormalities in the Chiari II malformation, II: tectal morphologic changes. J Ultrasound Med. 2009;28(1):29-35.
21. Wong SK, Barkovich JА, Сallen AL, Filly RA. Supratentorial Abnormalities in the Chiari II Malformation, III: The Interhemispheric Cyst. J Ultrasound Med. 2009;28(8):999-1006. DOI:10.7863/jum.2009.28.8.999
22. Filly MR, Filly RA, Barkovich AJ, Goldstein RB. Supratentorial Abnormalities in the Chiari II Malformation, IV: The Too-Far-Back Ventricle. J Ultrasound Med. 2010;29(2):243-48. DOI:10.7863/jum.2010.29.2.243
23. Finn M, Sutton D, Atkinson S, et al. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640-5. DOI:10.1002/uog.10088
24. Leibovitz Z, Shkolnik C, Krajden Haratz K, et al. Assessment of fetal midbrain and hindbrain in mid-sagittal cranial plane by three-dimensional multiplanar sonography. Part 1: comparison of new and established nomograms. Ultrasound Obstet Gynecol. 2014;44(5):575-80. DOI:10.1002/uog.13308.
25. Volcik KA, Shaw GM, Lammer EJ, et al. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res A Clin Mol Teratol. 2003;67(3):154-7. DOI:10.1002/bdra.10008
Авторы
Л.А. Чугунова*, А.А. Пискулина, К.В. Костюков
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России, Москва, Россия
*l_chugunova@oparina4.ru
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*l_chugunova@oparina4.ru
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России, Москва, Россия
*l_chugunova@oparina4.ru
________________________________________________
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*l_chugunova@oparina4.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
